Like Jackie Collins, I kept my cancer diagnosis a secret – and I don’t regret it
Keeping her illness from her sister Joan must have been one of the hardest decisions Jackie Collins had ever had to make – I did the same to protect my parents
Staying fit while pregnant: ‘we’re allowed to be flawed’
Remaining healthy and physically fit during pregnancy can be challenging, especially for mothers juggling other commitments. Amy Westervelt shares her tips
Bathtub booze and knock-off whisky: inside China’s fake alcohol industry
Drinkers are unwittingly knocking back fake alcohol brewed in bathtubs, which could lead to potentially serious health issues
What’s the best bit of the UN? No 7: UN Population Fund
All week we are looking at the United Nations’ vital agencies. Let us know what you think are the biggest successes and failures, using the form below
California’s healthcare industry can lead the way on stronger climate change regulation
Last week, dozens of businesses wrote letters to California lawmakers to urge passage of bills that would regulate emissions. Susan Vickers of Dignity Health explains why her company was one of them
Say goodbye to capitalism: welcome to the Republic of Wellbeing
If governments and companies are serious about meeting the Sustainable Development Goals then they’ll need to ditch their bad habits
Babies born in a recession ‘have worse health’
Icelandic study finds link between financial crisis and lower than average birth weights
Is the US ready to stomach eating bugs?
Bugs are a greener alternative source of protein, but US consumers are still grossed out by eating crickets. Will companies be able to make insect farming viable?
Sierra Leone’s secret FGM societies spread silent fear and sleepless nights
Traditional practitioners of female genital mutilation have established deep roots in Sierra Leonean culture and politics, creating a culture of fear among young women and posing a major obstacle to opponents of the custom
FDA approval of ‘female Viagra’ leaves bitter taste for critics
Addyi gains US marketing licence after third attempt, but questions remain about its effectiveness, potential side-effects and the true need for the drug